Table of Contents

A patent portfolio analysis San Francisco founders and investors rely on is built for a market where patents are graded before a term sheet is signed, not after a lawsuit is filed. This is the capital of venture capital, artificial intelligence and fintech, so the questions that matter here are what the estate is worth in due diligence, whether the claims survive Alice, and whether a young company has a defensible position to raise or sell on. San Francisco patents are also written in the shadow of the Northern District of California and the Federal Circuit, the two forums most likely to test them. That combination changes how the analysis has to be built.
Why a patent portfolio analysis San Francisco startups trust starts with value
San Francisco does not treat a patent portfolio as a trophy shelf. It treats it as an asset on a balance sheet that a venture partner, an acquirer or a lender is about to price. So the first job of the analysis is not to count filings; it is to tell the owner, honestly, what the estate protects, what it is worth in a negotiation, and where the holes are that a diligence lawyer will find first.
That reframes everything. A strong portfolio here is not the biggest one. It is the one whose claims actually read on the product, cover the roadmap, survive an eligibility challenge, and trace back to clean, assignable chains of title. A hundred pending applications that all claim an abstract idea are a liability dressed up as an asset, and a sophisticated San Francisco investor will discount them to zero in an afternoon.
We build the review around the decisions the company is about to make: raise a round, sell to a strategic buyer, license out, or defend against an assertion. Each of those uses the same underlying estate but asks a different question of it, so the analysis is scoped to the transaction on the table rather than delivered as a generic audit nobody reads.
Portfolios built for fundraising, VC due diligence and M&A
In most of the country a patent portfolio is examined once a dispute is already underway. In San Francisco it is examined every time capital changes hands. A Series A partner, an acquirer’s IP counsel, or an underwriter on a late-stage round will run a diligence read on the estate, and a weak or unexplained portfolio can shrink a valuation or sink a deal outright.
The city’s concentration makes this constant. San Francisco is headquarters to OpenAI, Anthropic, Salesforce, Uber, Airbnb, Stripe and Databricks, and to the venture firms that fund the next thousand companies behind them. Those buyers and backers know patents cold, and they ask hard questions: Do the claims cover the shipping product or an abandoned prototype? Is the eligibility risk quantified? Are inventor assignments executed and recorded at the USPTO? Are there freedom-to-operate exposures nobody has mapped?
A diligence-grade analysis answers those before the other side asks. It classifies each asset by what it protects and how strong it is, flags the eligibility and title problems that a buyer will surface, and separates the assets that add value from the ones that add only maintenance fees. For a founder, walking into the data room with that read already done is the difference between negotiating from strength and reacting to a red-flag memo written by the other side.
The same discipline drives freedom-to-operate work before a raise. Investors increasingly want comfort that the company can ship without infringing, so an FTO study on the core product often runs alongside the portfolio review, especially in crowded fintech and AI-infrastructure spaces.
Alice, section 101 and claim strength for software and fintech
The single largest risk in a San Francisco software or fintech portfolio is patent-eligible subject matter under 35 U.S.C. ยง 101. The Supreme Court’s decisions in Alice Corp. v. CLS Bank and Mayo v. Prometheus created a two-step test: first, are the claims directed to an abstract idea, law of nature or natural phenomenon; second, if so, do they add an inventive concept that amounts to significantly more than the idea itself. A claim that fails both steps is invalid, no matter how novel it is.
For this city that is not an abstract worry. Payment processing, data analytics, machine-learning pipelines, marketplace matching and financial-transaction methods are exactly the subject matter courts most often find abstract. A fintech patent that recites a generic computer performing a business method is a classic Alice casualty, and a portfolio full of them looks impressive until an eligibility screen deflates it.
So a serious eligibility read is central to any patent portfolio analysis San Francisco companies commission. We grade each software and fintech asset for ยง 101 exposure, distinguishing claims tied to a concrete technical improvement, which tend to survive, from claims that merely automate a known practice, which tend not to. Where drafting can still be fixed through continuations, we flag it while the application is pending rather than after issuance freezes the claims.
This eligibility grade is what turns a raw filing count into a defensible strength score. It tells an investor which assets would actually stop a competitor and which would evaporate on a motion to dismiss, and it tells the founder where to spend prosecution budget for real protection instead of paper.
AI inventions, USPTO guidance and the human-inventor rule
San Francisco is the epicentre of generative AI, so a modern portfolio analysis has to address who, or what, is named as an inventor. The rule is now settled: only a natural person can be an inventor on a U.S. patent. In Thaler v. Vidal the Federal Circuit held that an AI system cannot be listed as an inventor, and the Supreme Court declined to review it, leaving that as the final word.
What changed recently is the guidance for inventions made with AI assistance. On 28 November 2025 the USPTO issued revised inventorship guidance that rescinded its earlier 2024 approach, discontinued the joint-inventorship (Pannu) factors it had applied to AI, and now treats an AI model as a tool, much like simulation software or lab equipment, rather than a co-inventor. There is no special standard for AI-assisted inventions; the ordinary rule that a human must have conceived the claimed invention applies across the board.
For an AI company that is a diligence hotspot. If a filing rests on output a model generated with no meaningful human conception, its inventorship, and therefore its validity, is vulnerable. We check that named inventors reflect genuine human conception, that AI-assisted work is documented properly, and that the estate does not carry the kind of inventorship defect an acquirer or a challenger will exploit.
Where San Francisco patent disputes are tested
A portfolio is only as strong as it looks to the forums that will judge it, and in San Francisco those forums are unusually demanding. Federal patent suits filed in the city go to the U.S. District Court for the Northern District of California, whose San Francisco division sits at the Phillip Burton Federal Building at 450 Golden Gate Avenue. The Northern District is one of the busiest technology dockets in the country and has adopted detailed Patent Local Rules that force early, disciplined infringement and invalidity contentions.
That court is also where ยง 101 is fought hardest. Northern District judges routinely test software and fintech claims for eligibility early in a case, so an estate built for San Francisco has to be graded against the standard the local bench actually applies. A validity or eligibility read that would pass in a friendlier district is not enough here.
Two more forums shape the analysis. The Patent Trial and Appeal Board at the USPTO hears inter partes review petitions that can cancel claims over prior art in parallel with a district-court case, so the estate has to be stress-tested against the closest art before it is asserted. And every patent appeal, from both the Northern District and the PTAB, goes to the U.S. Court of Appeals for the Federal Circuit, whose claim construction and eligibility precedent ultimately governs. For hardware and imported goods, the U.S. International Trade Commission adds a Section 337 exclusion-order track at the border.
Building a first defensible estate and scoring its strength
Most San Francisco companies we help are young. They have a handful of issued patents and a stack of pending applications, and they need to know whether that adds up to a defensible position before the next round or the next competitor. A patent portfolio analysis San Francisco startups can act on has to be forward-looking, not just a snapshot of what has issued so far.
We score the estate on the dimensions that decide its real strength:
- Claim coverage: do the independent claims read on the current product and the near-term roadmap, or on something the company no longer builds
- Eligibility: how each software, fintech or AI asset holds up under the Alice/Mayo two-step, graded from durable to fragile
- Validity: exposure to the closest prior art and to an inter partes review before the PTAB
- Chain of title: whether every inventor assignment is executed and recorded, so the company actually owns what it claims to own
- White space and continuations: where pending applications should be steered to cover the roadmap and box in competitors
The output is a prioritised map, not a spreadsheet dump. It shows which assets to keep and enforce, which to let lapse to save maintenance fees, which pending cases to accelerate, and where a targeted new filing would close a gap. For a founder that map is a budget tool as much as a legal one, because it directs limited prosecution spend to the claims that will actually protect the company.
How we work with San Francisco founders, counsel and investors
Work reaches us in a few recurring postures: a founder preparing to raise or sell, a general counsel cleaning up an estate before diligence, an investor running a technical read on a target, or a company that has just been threatened and needs to know what it can assert back. Each starts the same way, with the claims, the product and an honest map between them.
We work from the issued patents and pending applications, the product and its roadmap, the prior art, and the assignment records at the USPTO. The deliverable states the position plainly: which assets are strong, which are eligibility or validity risks, where title is broken, and where the estate leaves the product exposed. Where the real battleground is validity, we scope the prior-art and litigation search that has to go with it; where it is exposure to others’ patents, we scope the freedom-to-operate and infringement work instead.
Because San Francisco runs on Pacific Time and the deals move fast, we build the analysis to a transaction clock. When a data room opens or a term sheet is live, the review is scoped to the questions that deal will ask and delivered in time to negotiate from it, not after the round has closed.
IP Landscape & Resources in San Francisco
Key intellectual-property authorities and venues relevant to San Francisco:
- United States Patent and Trademark Office — grants U.S. patents, records inventor assignments, and issued the November 2025 revised inventorship guidance treating AI as a tool rather than an inventor
- USPTO โ Patent Trial and Appeal Board — hears inter partes review petitions that can cancel asserted claims over prior art, a key validity risk for any San Francisco portfolio
- U.S. District Court for the Northern District of California — the federal court whose San Francisco division at the Phillip Burton Federal Building hears the region's patent suits under detailed Patent Local Rules
- U.S. Court of Appeals for the Federal Circuit — hears all patent appeals from the Northern District of California and the PTAB, setting the eligibility and claim-construction precedent that governs the estate
Request a Patent Portfolio Analysis in San Francisco
Request a Patent Portfolio Analysis in San Francisco
Send us your issued patents, pending applications and the product roadmap, or the target you are diligencing. We will scope a portfolio review built for fundraising, M&A or an Alice eligibility stress-test, and confirm cost and turnaround before any work begins.
Explore related PerspireIP services: Patent Portfolio Analysis · prior art & litigation search · patent monetization · our United States IP hub.
Frequently Asked Questions
Why do San Francisco investors care so much about a patent portfolio analysis?
Because in this market patents are priced during venture due diligence and M&A, not just in litigation. A Series A partner, an acquirer’s IP counsel or an underwriter will run a diligence read on the estate, and a weak or unexplained portfolio can cut a valuation or kill a deal. Having a diligence-grade analysis ready lets a founder negotiate from strength.
How does Alice section 101 affect a San Francisco software or fintech portfolio?
The Alice/Mayo two-step asks whether claims are directed to an abstract idea and, if so, whether they add an inventive concept. Payment methods, data analytics and marketplace software are exactly the subject matter courts most often find abstract, so many fintech patents are vulnerable. We grade each asset for section 101 exposure so you know which claims would actually survive a challenge.
Can an AI system be named as an inventor on our patents?
No. Under Thaler v. Vidal only a natural person can be an inventor, and the Supreme Court declined to review that ruling. The USPTO’s revised guidance of 28 November 2025 treats AI as a tool and requires that a human conceive the claimed invention. We check that your named inventors reflect genuine human conception so AI-assisted filings do not carry an inventorship defect.
Which court would hear a patent dispute over our San Francisco company’s patents?
The U.S. District Court for the Northern District of California, whose San Francisco division sits at the Phillip Burton Federal Building at 450 Golden Gate Avenue. It applies detailed Patent Local Rules and tests section 101 eligibility early. Appeals go to the Federal Circuit, and validity can also be challenged at the PTAB through inter partes review.
We are a young startup with only a few patents. Is an analysis worth it?
Yes, and it is most valuable early. We score claim coverage against your product and roadmap, eligibility under Alice, validity risk, and chain of title, then map which pending applications to accelerate and where to file next. That directs limited prosecution budget to the claims that will actually protect you before your next round.
Can you run a freedom-to-operate study before we fundraise?
Yes. Investors in crowded fintech and AI-infrastructure spaces increasingly want comfort that the company can ship without infringing others’ patents. We often run an FTO study on the core product alongside the portfolio review, so the data room addresses both the strength of your own estate and your exposure to others’.